LIU Zhen, ZHANG Ming-qian, ZHU Hong. Effect of Gualou Qumai Tang on Adipokines and Nephrin of Podocyte in Rats with Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(23): 134-139.
DOI:
LIU Zhen, ZHANG Ming-qian, ZHU Hong. Effect of Gualou Qumai Tang on Adipokines and Nephrin of Podocyte in Rats with Diabetic Nephropathy[J]. Chinese journal of experimental traditional medical formulae, 2017, 23(23): 134-139. DOI: 10.13422/j.cnki.syfjx.2017230134.
Effect of Gualou Qumai Tang on Adipokines and Nephrin of Podocyte in Rats with Diabetic Nephropathy
Objective: To observe the effects of Gualou Qumai Tang (GLQM) on serum lipids
adipokines and nephrin of podocyte in rats with diabetic nephropathy (DN) and discuss possible mechanism. Method: DN model was established by SD rats with high glucose and fat diet
unilateral nephrectomy and intraperitoneal injection of streptozotocin (STZ). After successful modeling
the rats were randomly divided into DN model group
low dose GLQM (GLQM-L)
medium dose GLQM (GLQM-M)
and high dose GLQM (GLQM-H) groups
valsartan group
and additionally a blank control group was set. The rats in GLQM low
medium and high dose groups received ig administration of 1.4
2.8 and 5.6 g·kg-1 GLQM respectively from 4th week; the rats in valsartan group received ig administration of 4.8×10-3 g·kg-1
and the rats in control and model group were given with 2.8 g·kg-1 distilled water
once a day for 12 weeks. Then the general status of the rats was observed; serum levels of triglyceride (TG)
cholesterol (CHO)
high density lipoprotein (HDL) and low density lipoprotein (LDL) were detected by automatic biochemical analyzer; serum levels of adiponectin (APN) and leptin (LEP) were detected by using enzyme-linked immunosorbent assay (ELISA). Then pathological changes of renal tissues were observed under light microscope
morphological changes of podocyte under electron microscope and nephrin expression in renal tissues was detected by using Western blot method. Result: As compared with the model group
the TG
CHO and LDL levels were significantly decreased in low
medium and high dose GLQM groups (P<0.05
P<0.01)
and HDL was increased significantly (P<0.05). The LEP level was significantly decreased in medium and high dose GLQM groups and valsartan group (P<0.01); APN was increased significantly (P<0.01). Pathological examination showed that the pathological changes of renal tissues and podocytes in the treatment groups were less than those in the model group. After the intervention of GLQM
the protein expression levels of nephrin were increased in Chinese medicine groups and valsartan group (P<0.05). Conclusion: GLQM can reduce renal tissue and podocyte damages and delay the development of DN by improving blood-lipid metabolism
interfering adipokine and maintaining the expressions of nephrin.